Breaking News

Biogen to pay $900 million to settle whistleblower case; a powerful Senate Democrat on drug pricing reform

 

Pharmalot Ed Silverman

STAT+: Biogen agrees to pay $900 million to settle whistleblower case alleging kickbacks and sham speaking events

By Ed Silverman

Steven Senn/AP

Biogen will pay $900 million to settle a suit filed by a former employee who alleged the company paid kickbacks to boost sales of MS drugs.

Read More

Powerful Senate Democrat outlines 'plenty' more drug pricing reforms to follow Medicare negotiation

By Nicholas Florko

STAT

In an interview with STAT's @rachelcohrs, Sen. Ron Wyden outlined a list of other drug pricing reforms he wants to take up.

Read More

Opinion: STAT+: 10 tips for vendors seeking to create or expand digital health and virtual health solutions

By Jeff Levin-Scherz and Andrey Ostrovsky

Adobe

Here are 10 tips for vendors to succeed in the increasingly competitive digital health and virtual health environments.

Read More

How does the brain decide what memories are good and bad? A new mouse study offers clues

By Jonathan Wosen

APStock

In a new study, scientists took a key step toward unraveling how our brain assigns positive or negative emotions to our experiences.

Read More

Wednesday, July 20, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments